Last Posted: May 26, 2020
- A newly developed capture-based sequencing panel for genomic assay of lung cancer.
Im Sun-Wha et al. Genes & genomics 2020 May - Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB).
Rolfo Christian et al. Critical reviews in oncology/hematology 2020 May 151102978 - Precision Medicine Exits the Hype Cycle and Enters into Productive Clinical Use.
Schmidt Ryan J et al. Clinics in laboratory medicine 2020 Jun 40(2) ix-x - Prognostic significance of immune cell populations identified by machine learning in colorectal cancer using routine hematoxylin & eosin stained sections.
Väyrynen Juha P et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 May - Targeted Therapy for Non-Small Cell Lung Cancer.
Noor Zorawar S et al. Seminars in respiratory and critical care medicine 2020 Jun 41(3) 409-434 - Information Sources Used by Oncologists to Understand Multi-marker Tumor Panel Tests for Cancer Patients.
Buckenmaier Susan S et al. Journal of cancer education : the official journal of the American Association for Cancer Education 2020 May - Personalized medicine in genetic epilepsies - possibilities, challenges, and new frontiers.
Helbig Ingo et al. Neuropharmacology 2020 Jan 172107970 - The Impact of Whole Genome Data on Therapeutic Decision-Making in Metastatic Prostate Cancer: A Retrospective Analysis.
Crumbaker Megan et al. Cancers 2020 May 12(5) - From precision medicine to imprecision medicine through limited diagnostic ability to detect low allelic frequency mutations.
Serrano María José et al. Translational lung cancer research 2020 Apr 9(2) 180-183 - Pharmacogenomic Testing to Guide Personalized Cancer Medicine Decisions in Private Oncology Practice: A Case Study.
Astras George et al. Frontiers in oncology 2020 10521
.png)
No hay comentarios:
Publicar un comentario